GB0904904D0 - Angiogenesis methods, medicaments and agents - Google Patents

Angiogenesis methods, medicaments and agents

Info

Publication number
GB0904904D0
GB0904904D0 GBGB0904904.0A GB0904904A GB0904904D0 GB 0904904 D0 GB0904904 D0 GB 0904904D0 GB 0904904 A GB0904904 A GB 0904904A GB 0904904 D0 GB0904904 D0 GB 0904904D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
agents
angiogenesis
methods
angiogenesis methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0904904.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leids Universitair Medisch Centrum LUMC
Original Assignee
Leids Universitair Medisch Centrum LUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leids Universitair Medisch Centrum LUMC filed Critical Leids Universitair Medisch Centrum LUMC
Priority to GBGB0904904.0A priority Critical patent/GB0904904D0/en
Publication of GB0904904D0 publication Critical patent/GB0904904D0/en
Priority to PCT/GB2010/000516 priority patent/WO2010109168A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0904904.0A 2009-03-23 2009-03-23 Angiogenesis methods, medicaments and agents Ceased GB0904904D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0904904.0A GB0904904D0 (en) 2009-03-23 2009-03-23 Angiogenesis methods, medicaments and agents
PCT/GB2010/000516 WO2010109168A2 (en) 2009-03-23 2010-03-23 Angiogenesis methods, medicaments and agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0904904.0A GB0904904D0 (en) 2009-03-23 2009-03-23 Angiogenesis methods, medicaments and agents

Publications (1)

Publication Number Publication Date
GB0904904D0 true GB0904904D0 (en) 2009-05-06

Family

ID=40639952

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0904904.0A Ceased GB0904904D0 (en) 2009-03-23 2009-03-23 Angiogenesis methods, medicaments and agents

Country Status (2)

Country Link
GB (1) GB0904904D0 (en)
WO (1) WO2010109168A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140040694A (en) * 2011-01-18 2014-04-03 에버리스트 게노믹스, 인크. Prognostic signature for colorectal cancer recurrence
CN108085336A (en) * 2016-11-21 2018-05-29 中国科学院上海生命科学研究院 EGFP expression vector establishments based on col2a1 promoters and the application in transgenic zebrafish

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US5168053A (en) 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5149796A (en) 1989-08-31 1992-09-22 City Of Hope Chimeric DNA-RNA catalytic sequences
US5180818A (en) 1990-03-21 1993-01-19 The University Of Colorado Foundation, Inc. Site specific cleavage of single-stranded dna
WO1995032425A1 (en) 1994-05-23 1995-11-30 Smithkline Beecham Corporation Encoded combinatorial libraries
US6225118B1 (en) 1997-10-01 2001-05-01 Biocure Limited Multicellular in vitro assay of angiogenesis
US20100278810A1 (en) * 2007-05-24 2010-11-04 Frank Kuhnert Methods of Modulating Angiogenesis

Also Published As

Publication number Publication date
WO2010109168A2 (en) 2010-09-30
WO2010109168A3 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
GB0917044D0 (en) Agents, uses and methods
GB0916335D0 (en) Medicaments
GB0917054D0 (en) Agents, uses and methods
IL222930A0 (en) Chlorotoxin variants, conjugates and methods for their use
EP2518147A4 (en) Diacylglycerole acyltranferase gene, and use thereof
GB0908957D0 (en) Therapeutic agents
HK1167597A1 (en) Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics -2e4e-
IL220526A0 (en) Kokumi-imparting agent
EP2478768A4 (en) Anti-plant-virus agent
ZA201209595B (en) N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
IL220527A0 (en) Kokumi-imparting agent
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
HK1171225A1 (en) Ethynyl derivatives
EP2515903A4 (en) Compounds, preparations and uses thereof
EP2433502A4 (en) Bitterness-suppressing agent
GB0900484D0 (en) Therapeutic agent
HK1170277A1 (en) Medicinal agent case
GB0915319D0 (en) Combination medicament
GB0914738D0 (en) Inhalers
HK1164861A1 (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
GB0904904D0 (en) Angiogenesis methods, medicaments and agents
AP2011006033A0 (en) Simalikalactone E and use thereof as a medicament.
SI2421864T1 (en) 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof
AP2011005789A0 (en) Sulfamoyl-phenyl-ureido benzamidine-derivatives asantimalarial agents.
GB0917792D0 (en) Delivery agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)